Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GEN1055 |
Trade Name | |
Synonyms | GEN-1055|GEN 1055|HexaBody-OX40|BNT315 |
Drug Descriptions |
GEN1055 is an agonist antibody targeting TNFRSF4 (OX40, CD134), which potentially induces proliferation of CD4+ and CD8+ T lymphocytes and enhances antitumor immune response (Immuno-Oncology and Technology 20 (2023)). |
DrugClasses | OX40 Antibody 14 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GEN1055 | GEN1055 | 0 | 0 |
GEN1055 + Pembrolizumab | GEN1055 Pembrolizumab | 0 | 1 |